How we know
Every link on this study, and who decided it
The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.
Why Olaparib is on this study
- The record lists it as a treatment, written “Olaparib Pill”.
- Claude Opus 5.5 judged it given beside what the study tests (partner). Nov 16 (day only)“Partner of new ceralasertib in ovarian cancer”
- The role rule says the same.
- So Olaparib's page lists this study under “Given beside what is tested”.
Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.
Olaparib
From the registry record3 judgments on this linkAll judgments on this study
| When | Link | Judge | Decision | State |
|---|---|---|---|---|
| 1 version of the record seen on ClinicalTrials.gov, Nov 10 · changes seen, not judgments | ||||
| Nov 3 | Olaparib | Claude Opus 5.5 | Background | Replaced |
| Nov 3 | Ceralasertib | Claude Opus 5.5 | Tested | Replaced |
| Nov 10 | The record itself | Rule based · nightly check | Reading set aside | Current |
| Nov 16 | The record itself | Rule based · nightly check | Read again | Current |
| Nov 16 | Olaparib | Claude Opus 5.5 | Background · partner | Current |
| Nov 16 | Ceralasertib | Claude Opus 5.5 | Tested | Current |
| Nov 18 | Olaparib | Rule based · role rule | Background | Agrees |
| Nov 18 | Ceralasertib | Rule based · role rule | Tested | Agrees |
The rules, in plain words
“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.
Which drugs a study tests
Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.
Where the whole record has been read, that reading's answer replaces the rule's.
When a study changes after it was read
Every night, studies whose record changed are compared with the last reading. A change to sites or dates leaves the reading as it is; a reworded entry keeps it; a change to the treatments or conditions marks it to be read again.
Until it is read again, the page shows the last reading and says so.